Loading
Latest filing published 25 Jan 2023 for Calithera Biosciences, Inc., €115. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Eric Sjogren in Calithera Biosciences, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 27 October 2021 to 23 January 2023, the count stands at 5 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 25 January 2023 with a share grant (€115) in Calithera Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations